Taro Pharmaceutical Industries (TARO)
Add to Watchlists Create an Alert
60.45
-2.77 -4.38%
NYSE
May 24, 5:00PM
BATS Real time
Currency in USD
Taro Pharmaceutical Industries Interest Expense:
0.00 for Dec. 31, 2012Taro Pharmaceutical Industries Historical Interest Expense Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.00 |
| Sept. 30, 2012 | 0.00 |
| June 30, 2012 | 0.39M |
| March 31, 2012 | 1.00M |
| Dec. 31, 2011 | 1.763M |
| Sept. 30, 2011 | 1.507M |
| June 30, 2011 | 0.624M |
| March 31, 2011 | 0.778M |
| Dec. 31, 2010 | 0.362M |
| Sept. 30, 2010 | 2.767M |
| June 30, 2010 | 1.635M |
| March 31, 2010 | 1.277M |
| Dec. 31, 2009 | -3.954M |
| Sept. 30, 2009 | 3.445M |
| June 30, 2009 | 1.873M |
| March 31, 2009 | 2.266M |
| Dec. 31, 2008 | -12.77M |
| Sept. 30, 2008 | 4.547M |
| June 30, 2008 | 3.398M |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
| June 30, 2000 | Go Pro |
| March 31, 2000 | Go Pro |
| Dec. 31, 1999 | Go Pro |
| Sept. 30, 1999 | Go Pro |
| June 30, 1999 | Go Pro |
| March 31, 1999 | Go Pro |
| Dec. 31, 1998 | Go Pro |
| Sept. 30, 1998 | Go Pro |
| June 30, 1998 | Go Pro |
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
TARO Interest Expense Benchmarks
| Companies | |
|---|---|
| Perrigo Company | 16.07M |
| Valeant Pharmaceuticals International | 155.32M |
| Pernix Therapeutics | 0.00 |
TARO Interest Expense Rankings
| Overall |
99th percentile 45 of 8009 |
| Sector |
98th percentile 10 of 687 in Healthcare |
| Industry |
92nd percentile 5 of 69 in Drug Manufacturers - Specialty & Generic |
TARO Interest Expense Range, Past 5 Years
| Minimum | -12.77M | Dec 2008 |
| Maximum | 4.547M | Sep 2008 |
| Average | 0.5741M |
